Healing & repair

Wolverine blend (BPC-157 + TB-500)

A two-peptide repair stack sold as one vial: the components have animal data, the combination has none.

Anecdotal evidenceNot approvedAdd to compare

What it is

A prepackaged mixture of BPC-157 and TB-500, usually 10 mg of each per vial, sold as a research blend for injury recovery. Neither component is an approved medicine, the combination has never been studied in a clinical trial, and both are prohibited in sport.

How it works

1
BPC-157 is proposed to act through VEGFR2 and nitric-oxide pathways in animal wound-healing models.
2
TB-500, a fragment of thymosin beta-4, is studied for actin regulation and cell migration in animal models.
3
The blend is sold on the idea that one drives blood-vessel formation and the other cell migration, so they complement each other.
4
That complementarity is a sales narrative; no study has compared the combination with either peptide alone.
5
Neither mechanism has been confirmed in controlled human studies.

What it's studied for

Tendon, muscle and ligament injury claims

Gut-lining repair claims

Post-surgical recovery claims

All of these rest on animal models or anecdote rather than trials

Reported and studied effects

Reported faster recovery in user accounts
Reduced pain claimed but never measured in a study
Animal data show accelerated tissue closure for the individual peptides

Research protocol notes

Research context only

Research context only — no human protocol exists for the blend. Community schedules use roughly 250–500 micrograms of each peptide once daily, or the same total split morning and evening, for 6–12 weeks. Because the vial is fixed at a 1:1 ratio, adjusting one component changes the other, and syringe units depend entirely on how the vial was reconstituted.

These figures are described so you can understand what researchers did. They are not a dose, a schedule, or a suggestion — and they are not a substitute for a doctor.

Possible side effects and contraindications

Safety profile

Possible side effects

Injection-site pain and redness
Headache, nausea and fatigue reported by users
Compounds proposed to promote blood-vessel growth warrant caution in anyone with a cancer history
No safety data for the combination

Contraindications and cautions

Not established
Cancer history
Pregnancy, breastfeeding and childhood
Prohibited in competitive sport

A side-effect list is never complete, and these are not the only situations that warrant caution. Anything unexpected, or anything you are unsure about, should be discussed with a doctor before use.

Evidence assessment

Anecdotal evidenceNo controlled human data

No controlled human data

The individual peptides have animal and limited human data; the marketed combination has never been tested and no regulator has assessed either component as a medicine.

References

References link to published literature, regulator pages or literature indexes. Where a link points to a search, it collects the peer-reviewed work on that molecule rather than a single study.

Compare Wolverine blend (BPC-157 + TB-500) with another peptide →

Related peptides

Other entries in Healing & repair.

All Healing & repair peptides →

Healing & repair

BPC-157

A synthetic fragment of a gastric protein, widely promoted online for injury recovery. Human trial evidence is very thin; almost all data comes from animal studies.

Limited evidenceNot approved

Healing & repair

KLOW blend (TB-500, BPC-157, KPV, GHK-Cu)

A four-peptide repair and skin stack: animal data on each part, nothing at all on the combination.

Anecdotal evidenceNot approved

Healing & repair

KPV

A three-amino-acid fragment of alpha-MSH promoted for gut and skin inflammation. Anti-inflammatory in cells and animals; there are no human trials at all.

Anecdotal evidenceNot approved